 |
|
nelfinavir mesylate
The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Viracept | | |
|
|
